Triple

T22690357
Position Surface form Disambiguated ID Type / Status
Subject IL-17A E561033 entity
Predicate bindsTo P37017 FINISHED
Object IL-17 receptor complex NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: IL-17 receptor complex | Statement: [IL-17A, bindsTo, IL-17 receptor complex]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: IL-17 receptor complex
Context triple: [IL-17A, bindsTo, IL-17 receptor complex]
  • A. IL-17RA chosen
    IL-17RA is a cell surface receptor subunit that mediates signaling for interleukin-17 family cytokines, playing a key role in inflammatory and autoimmune responses.
  • B. IL-17A
    IL-17A is a pro-inflammatory cytokine produced mainly by Th17 cells that plays a key role in the pathogenesis of several autoimmune and inflammatory diseases.
  • C. IL-64
    IL-64 is a major east–west state highway in Illinois that runs from the Mississippi River through the Chicago metropolitan area.
  • D. Janus kinase 1
    Janus kinase 1 is a tyrosine kinase enzyme involved in cytokine receptor signaling and immune regulation, making it an important therapeutic target in inflammatory and autoimmune diseases.
  • E. Bruton tyrosine kinase
    Bruton tyrosine kinase is a key signaling enzyme in B cells that plays a crucial role in their development and function and is a major therapeutic target in certain blood cancers and autoimmune diseases.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454d71b48190a1f80af9f82b6fcf completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1789a1fd08190bce5fa0babe695d3 completed April 29, 2026, 3:18 a.m.
Created at: April 17, 2026, 3:13 p.m.